Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Solid Biosciences Inc. - Common Stock (NQ: SLDB )

4.030 +0.110 (+2.81%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,482,915
Open 4.490
Bid (Size) 3.980 (6)
Ask (Size) 4.100 (7)
Prev. Close 3.920
Today's Range 3.940 - 4.590
52wk Range 3.900 - 15.05
Shares Outstanding 19,601,539
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Solid Biosciences advances gene therapies for muscular and cardiac diseases, gaining FDA clearance for SGT-212 and targeting key 2025 milestones. 
Via Benzinga
Exposures Product Safety
Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
+3.33%
+3.33%
1 Month
-21.14%
-21.14%
3 Month
-41.68%
-41.68%
6 Month
-42.51%
-42.51%
1 Year
-49.94%
-49.94%

More News

Read More
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst
Via Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
SLDB Stock Earnings: Solid Biosciences Beats EPS for Q2 2024
Via InvestorPlace
This Planet Fitness Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
Via Investor's Business Daily
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Via Investor's Business Daily
Exposures Product Safety
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
Via InvestorPlace
SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
Via Investor's Business Daily
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
5 Value Stocks In The Healthcare Sector
Via Benzinga
Top 4 Health Care Stocks You May Want To Dump In February
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.